Home › Funds › Gouws Capital LLC › ABBV

Gouws Capital LLC position in ABBV

ABBVIE INC · Health Care

Gouws Capital LLC reported holding 2,700 shares of ABBV (ABBVIE INC) in its Q3 2026 13F filing — a position valued at US$706K, representing 0.33% of its reported portfolio and ranking #31 among its reported holdings. Gouws Capital LLC has disclosed ABBV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)2.70K sh
Reported value held$706.29K
Portfolio Weight0.33%
First reportedQ3 2023
Last changeHold
Updated2026-10-09

Last updated: 2026-10-09 · Source: SEC EDGAR Form 13F-HR

How Gouws Capital LLC's ABBV position evolved

Gouws Capital LLC first disclosed a stake in ABBV in Q3 2023 at 3,355 shares (US$500K). The position peaked in Q3 2026 at 2,700 shares, worth US$706K. Across 13 filings, Gouws Capital LLC increased the stake 3 time(s), trimmed it 3 time(s) and left it unchanged 6 time(s). The most recent filing (Q3 2026) shows 2,700 shares valued at US$706K. Notable position changes include a 34% trim in Q4 2023 (shares rose 19% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 3.35K $500.10K New
Q4 2023 2.23K $345.58K Reduce
Q1 2024 2.23K $406.08K Hold
Q2 2024 2.35K $403.93K Add
Q3 2024 2.35K $465.06K Hold
Q4 2024 2.35K $418.48K Hold
Q1 2025 2.42K $505.99K Add
Q2 2025 2.85K $529.95K Add
Q3 2025 2.85K $661.05K Hold
Q4 2025 2.85K $652.34K Hold
Q1 2026 2.83K $616.59K Reduce
Q2 2026 2.70K $679.43K Reduce
Q3 2026 2.70K $706.29K Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABBV and 13F data

ABBV (ABBVIE INC) is a Health Care company. 35 other funds we track also report a position in ABBV — the largest reported positions include Vanguard Group (US$41.31B), BlackRock Inc (US$37.62B), VANGUARD CAPITAL MANAGEMENT LLC (US$29.04B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABBV

All ABBV fund holders →

FAQ

How long has Gouws Capital LLC held ABBV?

Gouws Capital LLC has disclosed ABBV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Gouws Capital LLC's current position in ABBV?

As of Q3 2026, Gouws Capital LLC holds 2.70K shares of ABBV (ABBVIE INC), valued at $706.29K, representing 0.33% of its reported portfolio and ranking #31.

Has Gouws Capital LLC been buying or selling ABBV?

In the latest 13F filing (Q3 2026), Gouws Capital LLC held unchanged its position in ABBV. The position peaked in Q3 2026 at 2.70K shares.

Which other funds hold ABBV?

Other major institutional holders of ABBV include Vanguard Group, BlackRock Inc, VANGUARD CAPITAL MANAGEMENT LLC, among 35 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.